Scheduling Review Timeline Still no safe banking or scheduling review. Interest rates are going up. Not sure how some MSOSs are surviving. The good news is that Curaleaf has been trending up for months and any catalyst would help. Well, at least the DEA has asked for a timeline from HHS for the scheduling review (so much for expeditious).